China Medicine(OTC) CHME

China Medicine Corporation is a prominent player in the healthcare sector, specializing in the production and distribution of prescription and over-the-counter drugs, traditional Chinese medicine products, and medical devices. The company operates a comprehensive sales network across China, catering to various medical needs.

Products and Services

• Prescription and over-the-counter pharmaceuticals
• Traditional Chinese medicine and dietary supplements
• Medical devices and formulations for various health conditions

Growth Outlook

• Strong demand for traditional Chinese medicine supports revenue growth
• Expansion of product offerings enhances market reach
• Increasing healthcare spending in China presents growth opportunities

Financial Highlights

• Recent quarterly revenue of $17.55 million shows consistent performance
• Trailing twelve months (TTM) net profit margin stands at 2.65%
• Current ratio of 2.10 indicates strong liquidity position

China Medicine Corporation has established itself as a significant entity in the pharmaceutical industry, leveraging the growing interest in traditional Chinese medicine alongside modern healthcare solutions. The company's diverse product range addresses various health issues, from oncology to respiratory infections, positioning it well within the expanding healthcare market in China. Recent financial performance indicates a solid revenue stream, with the latest quarterly revenue reaching $17.55 million, reflecting the company's ability to maintain consistent sales. The TTM net profit margin of 2.65% suggests effective cost management and operational efficiency, while a current ratio of 2.10 highlights a robust liquidity position, ensuring the company can meet its short-term obligations. Overall, China Medicine Corporation presents a compelling opportunity for investors interested in the healthcare sector, particularly in the context of China's evolving medical landscape.